Ocean Biomedical (OCEAW) Stock Price, News & Analysis

Company Overview

Ocean Biomedical, Inc. is a clinical‐stage biotechnology company dedicated to the discovery, development and commercialization of vaccines and immunotherapies targeting infectious diseases and oncology. The company applies a proprietary immunogen design platform to identify novel antigens and therapeutic antibodies, with an emphasis on addressing multidrug‐resistant bacterial pathogens and select tumor indications.

Ocean Biomedical’s research engine combines structural biology, high‐throughput screening and computational modelling to accelerate lead identification and optimization. Its preclinical pipeline includes candidate conjugate vaccines aimed at antibiotic‐resistant strains and monoclonal antibody programs designed to enhance anticancer immune responses. Through iterative in vitro and in vivo validation, the company seeks to advance multiple assets toward translational studies and eventual clinical development.

Headquartered in Cambridge, Massachusetts, Ocean Biomedical collaborates with academic institutions and contract research organizations across the United States to leverage expert scientific and manufacturing capabilities. The management team brings together seasoned professionals in drug discovery, vaccine development and biotechnology commercialization, positioning the company to navigate preclinical milestones and prepare for future clinical evaluation.

Key Stats

• Today's Range: $0.0038 to $0.0098
• 50-Day Range: $0.0026 to $0.0194
• 52-Week Range: $0.00 to $0.18
• Volume: 5,100 shs
• Average Volume: 59,023 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

OCEAW Stock Analysis - Frequently Asked Questions

How have OCEAW shares performed this year?

Ocean Biomedical's stock was trading at $0.0232 at the beginning of 2025. Since then, OCEAW shares have decreased by 57.8% and is now trading at $0.0098.

How do I buy shares of Ocean Biomedical?

Shares of OCEAW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:OCEAW
• CIK: 1869974
• Web: www.oceanbiomedical.com
• Phone: 401-444-7375
• Fax: N/A
• Employees: 2
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A